Proteus mirabilis biofilms and catheter-associated urinary tract infections

Proteus mirabilis inhabits the environment and causes a number of infections including those of the skin, respiratory tract, wounds and urinary tract. These organisms express virulence factors associated with adhesion, motility, immunoavoidance, nutrient acquisition, host damage, as well as biofilm formation. P. mirabilis produces biofilms in diverse habitats with those formed in the human host playing a key role in indwelling device infections. The most studied P. mirabilis biofilms are those formed when the organism is grown in urine, resulting in unique features including the presence of swarmer cells and struvite and hydroxyapatite crystals upon growth in urine. Factors relevant to P. mirabilis biofilm formation include adhesion factors, proteins involved in LPS production, transporters, transcription factors, two component systems, communication factors and enzymes. P. mirabilis biofilm research will lead to a better understanding of the disease process and will subsequently lead to the development of new prevention, and treatment options.

[1]  Bruce P. Lee,et al.  First prize: Novel uropathogen-resistant coatings inspired by marine mussels. , 2008, Journal of endourology.

[2]  H. Lai,et al.  Modulation of Swarming and Virulence by Fatty Acids through the RsbA Protein in Proteus mirabilis , 2004, Infection and Immunity.

[3]  D. Stickler,et al.  Encrustation of indwelling urethral catheters by Proteus mirabilis biofilms growing in human urine. , 1998, The Journal of hospital infection.

[4]  K. Luh,et al.  Role of RsmA in the regulation of swarming motility and virulence factor expression in Proteus mirabilis. , 2003, Journal of medical microbiology.

[5]  H. Mobley,et al.  Proteus mirabilis MR/P fimbrial operon: genetic organization, nucleotide sequence, and conditions for expression , 1994, Journal of bacteriology.

[6]  D. Stickler,et al.  Complications of urinary tract infections associated with devices used for long-term bladder management. , 1994, The Journal of hospital infection.

[7]  M. Beattie,et al.  Silver alloy vs. uncoated urinary catheters: a systematic review of the literature. , 2011, Journal of clinical nursing.

[8]  R. Russell,et al.  Contribution of Proteus mirabilis urease to persistence, urolithiasis, and acute pyelonephritis in a mouse model of ascending urinary tract infection , 1993, Infection and immunity.

[9]  D. Stickler,et al.  Why are Foley catheters so vulnerable to encrustation and blockage by crystalline bacterial biofilm? , 2003, Urological Research.

[10]  T. Wood,et al.  Quorum-sensing antagonist (5Z)-4-bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone influences siderophore biosynthesis in Pseudomonas putida and Pseudomonas aeruginosa , 2005, Applied Microbiology and Biotechnology.

[11]  B. Jones,et al.  Role of swarming in the formation of crystalline Proteus mirabilis biofilms on urinary catheters. , 2005, Journal of medical microbiology.

[12]  R. Martinuzzi,et al.  Structure of Proteus mirabilis biofilms grown in artificial urine and standard laboratory media. , 2007, FEMS microbiology letters.

[13]  D. Musher,et al.  Urease. The primary cause of infection-induced urinary stones. , 1976, Investigative urology.

[14]  Z. Sidorczyk,et al.  Potential virulence factors of Proteus bacilli. , 1997, Microbiology and molecular biology reviews : MMBR.

[15]  D. Stickler,et al.  The migration of Proteus mirabilis and other urinary tract pathogens over Foley catheters , 2002, BJU international.

[16]  J. Pulido,et al.  Biofilm and scleral buckle-associated infections. A mechanism for persistence. , 1991, Ophthalmology.

[17]  J W Warren,et al.  Fever, bacteremia, and death as complications of bacteriuria in women with long-term urethral catheters. , 1987, The Journal of infectious diseases.

[18]  D. Stickler,et al.  Bacterial biofilms and the encrustation of urethral catheters , 1996 .

[19]  G. Reid,et al.  Microbial adhesion and biofilm formation on ureteral stents in vitro and in vivo. , 1992, The Journal of urology.

[20]  C. G. Moreira,et al.  Aggregative adherence of uropathogenic Proteus mirabilis to cultured epithelial cells. , 2007, FEMS immunology and medical microbiology.

[21]  G. Williams,et al.  Some observations on the diffusion of antimicrobial agents through the retention balloons of foley catheters. , 2007, The Journal of urology.

[22]  R. Martinuzzi,et al.  Use of quorum sensing antagonists to deter the formation of crystalline Proteus mirabilis biofilms. , 2009, International journal of antimicrobial agents.

[23]  T. Rukavina,et al.  Microbial colonization of tracheoesophageal voice prostheses (Provox2) following total laryngectomy , 2010, European Archives of Oto-Rhino-Laryngology.

[24]  R. Venkatesan,et al.  16S rDNA sequence analysis of culturable marine biofilm forming bacteria from a ship's hull , 2010, Biofouling.

[25]  D. Davies,et al.  A Fatty Acid Messenger Is Responsible for Inducing Dispersion in Microbial Biofilms , 2008, Journal of bacteriology.

[26]  H. Mobley,et al.  The high-affinity phosphate transporter Pst is a virulence factor for Proteus mirabilis during complicated urinary tract infection. , 2008, FEMS immunology and medical microbiology.

[27]  J. Nickel,et al.  The ecology and pathogenicity of urease-producing bacteria in the urinary tract. , 1988, Critical reviews in microbiology.

[28]  D. Stickler,et al.  Reduced Susceptibility of Proteus mirabilis to Triclosan , 2008, Antimicrobial Agents and Chemotherapy.

[29]  M. Waters,et al.  A Sensor To Detect the Early Stages in the Development of Crystalline Proteus mirabilis Biofilm on Indwelling Bladder Catheters , 2006, Journal of Clinical Microbiology.

[30]  G. Reid,et al.  In-vitro activity of triclosan-eluting ureteral stents against common bacterial uropathogens. , 2006, Journal of endourology.

[31]  A. D. Russell,et al.  A strategy for the control of catheter blockage by crystalline Proteus mirabilis biofilm using the antibacterial agent triclosan. , 2005, European urology.

[32]  D. Rigby,et al.  A study of the structure of the crystalline bacterial biofilms that can encrust and block silver Foley catheters , 2009, Urological Research.

[33]  J. Lawrence,et al.  Proteus mirabilis biofilm protection against struvite crystal dissolution and its implications in struvite urolithiasis. , 1991, The Journal of urology.

[34]  C. Winters,et al.  Proteus mirabilis biofilms and the encrustation of urethral catheters , 2004, Urological Research.

[35]  D. Musher,et al.  Role of urease in pyelonephritis resulting from urinary tract infection with Proteus. , 1975, The Journal of infectious diseases.

[36]  D. Beauchemin,et al.  Unique ability of the Proteus mirabilis capsule to enhance mineral growth in infectious urinary calculi , 1994, Infection and immunity.

[37]  R. Belas,et al.  The Genera Proteus, Providencia, and Morganella , 2006 .

[38]  T. Ciach,et al.  In vitro multicompartmental bladder model for assessing blockage of urinary catheters: effect of hydrogel coating on dynamics of Proteus mirabilis growth. , 2010, Urology.

[39]  M. Waters,et al.  A clinical assessment of the performance of a sensor to detect crystalline biofilm formation on indwelling bladder catheters , 2006, BJU international.

[40]  E. Mahenthiralingam,et al.  Genotyping demonstrates that the strains of Proteus mirabilis from bladder stones and catheter encrustations of patients undergoing long-term bladder catheterization are identical. , 2004, The Journal of urology.

[41]  R. Suvanasuthi,et al.  The Ability of Proteus mirabilis To Sense Surfaces and Regulate Virulence Gene Expression Involves FliL, a Flagellar Basal Body Protein , 2005, Journal of bacteriology.

[42]  H. Mobley,et al.  Construction of a urease-negative mutant of Proteus mirabilis: analysis of virulence in a mouse model of ascending urinary tract infection , 1990, Infection and immunity.

[43]  J. Guggenbichler,et al.  Prevention of catheter-related infections: the potential of a new nano-silver impregnated catheter. , 2004, International journal of antimicrobial agents.

[44]  S. Percival,et al.  The effect of EDTA instillations on the rate of development of encrustation and biofilms in Foley catheters , 2009, Urological Research.

[45]  T. Knoll,et al.  [Pathophysiology, diagnosis and conservative therapy of non-calcium kidney calculi]. , 2003, Therapeutische Umschau. Revue therapeutique.

[46]  S. Gorman,et al.  The use of lytic bacteriophages in the prevention and eradication of biofilms of Proteus mirabilis and Escherichia coli. , 2010, FEMS immunology and medical microbiology.

[47]  B. Rittmann,et al.  Biofilm detachment mechanisms in a liquid‐fluidized bed , 1991, Biotechnology and bioengineering.

[48]  Michael J. Long,et al.  An electrified catheter to resist encrustation by Proteus mirabilis biofilm. , 2005, The Journal of urology.

[49]  Adrian Russell,et al.  Control of encrustation and blockage of Foley catheters , 2003, The Lancet.

[50]  M. Regué,et al.  The inner-core lipopolysaccharide biosynthetic waaE gene: function and genetic distribution among some Enterobacteriaceae. , 2002, Microbiology.

[51]  W. Anthony,et al.  A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. , 1982, The Journal of infectious diseases.

[52]  H. Mobley,et al.  Urease-positive bacteriuria and obstruction of long-term urinary catheters , 1987, Journal of clinical microbiology.

[53]  David S. Jones,et al.  Strategies for the development of the urinary catheter , 2007, Expert review of medical devices.

[54]  D. Stickler,et al.  Which indwelling urethral catheters resist encrustation by Proteus mirabilis biofilms? , 1997, British journal of urology.

[55]  L. Clapham,et al.  The influence of bacteria on struvite crystal habit and its importance in urinary stone formation , 1990 .

[56]  D. Stickler,et al.  Modulation of crystalline Proteus mirabilis biofilm development on urinary catheters. , 2006, Journal of medical microbiology.

[57]  M. Liu,et al.  Proteus mirabilis pmrI, an RppA-Regulated Gene Necessary for Polymyxin B Resistance, Biofilm Formation, and Urothelial Cell Invasion , 2010, Antimicrobial Agents and Chemotherapy.

[58]  H. Mobley,et al.  The high-affinity phosphate transporter Pst in Proteus mirabilis HI4320 and its importance in biofilm formation. , 2009, Microbiology.

[59]  A. Jansen,et al.  Mannose-Resistant Proteus-Like Fimbriae Are Produced by Most Proteus mirabilis Strains Infecting the Urinary Tract, Dictate the In Vivo Localization of Bacteria, and Contribute to Biofilm Formation , 2004, Infection and Immunity.

[60]  H. Mobley,et al.  Complicated Catheter-Associated Urinary Tract Infections Due to Escherichia coli and Proteus mirabilis , 2008, Clinical Microbiology Reviews.

[61]  P. Zunino,et al.  Effect of Ibicella lutea on uropathogenic Proteus mirabilis growth, virulence, and biofilm formation. , 2009, Journal of infection in developing countries.

[62]  D. Stickler,et al.  The encrustation and blockage of long-term indwelling bladder catheters: a way forward in prevention and control , 2010, Spinal Cord.